LAZARD ASSET MANAGEMENT LLC - SAGE THERAPEUTICS INC ownership

SAGE THERAPEUTICS INC's ticker is SAGE and the CUSIP is 78667J108. A total of 287 filers reported holding SAGE THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is 1.28 and the average weighting 0.2%.

Quarter-by-quarter ownership
LAZARD ASSET MANAGEMENT LLC ownership history of SAGE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$1,208,000
+1758.5%
27,292
+3033.4%
0.00%
Q1 2021$65,000
-35.6%
871
-47.5%
0.00%
Q3 2020$101,000
-70.1%
1,658
-79.7%
0.00%
-100.0%
Q2 2020$338,000
+724.4%
8,151
+462.1%
0.00%
Q1 2020$41,000
-95.9%
1,450
-73.1%
0.00%
-100.0%
Q2 2019$988,000
+15.2%
5,4000.0%0.00%
+100.0%
Q1 2019$858,000
+66.0%
5,4000.0%0.00%0.0%
Q4 2018$517,000
-32.2%
5,4000.0%0.00%0.0%
Q3 2018$762,000
-59.5%
5,400
-55.1%
0.00%
-66.7%
Q2 2018$1,882,000
+116.6%
12,029
+122.8%
0.00%
+200.0%
Q1 2018$869,000
-41.6%
5,400
-40.3%
0.00%
-66.7%
Q4 2017$1,488,000
+50.3%
9,045
-43.1%
0.00%
+50.0%
Q3 2017$990,000
-51.2%
15,900
-37.6%
0.00%
-50.0%
Q2 2017$2,030,000
+8.2%
25,500
-3.4%
0.00%0.0%
Q1 2017$1,876,000
-35.9%
26,400
-53.9%
0.00%
-33.3%
Q4 2016$2,925,000
-22.1%
57,300
-29.8%
0.01%
-14.3%
Q3 2016$3,757,000
+117.7%
81,600
+42.4%
0.01%
+75.0%
Q2 2016$1,726,000
-6.0%
57,3000.0%0.00%0.0%
Q1 2016$1,837,000
-45.0%
57,3000.0%0.00%
-50.0%
Q4 2015$3,340,000
+26.5%
57,300
-8.2%
0.01%
+33.3%
Q3 2015$2,641,000
-43.2%
62,425
-2.0%
0.01%
-40.0%
Q2 2015$4,650,00063,7000.01%
Other shareholders
SAGE THERAPEUTICS INC shareholders Q3 2019
NameSharesValueWeighting ↓
GREAT POINT PARTNERS LLC 1,966,688$120,204,00010.81%
Integral Health Asset Management, LLC 230,000$14,058,0004.30%
Asymmetry Capital Management, L.P. 102,462$6,262,0004.02%
ACUTA CAPITAL PARTNERS, LLC 225,000$13,752,0003.74%
DAFNA Capital Management LLC 158,306$9,676,0003.14%
Bain Capital Life Sciences Investors, LLC 499,100$30,505,0002.84%
Boxer Capital, LLC 1,094,000$66,865,0002.31%
Palo Alto Investors LP 590,200$36,073,0001.98%
Logos Global Management LP 250,000$15,280,0001.96%
Bellevue Group AG 1,579,504$96,539,0001.33%
View complete list of SAGE THERAPEUTICS INC shareholders